Steven Cohen's WST Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 659,253 shares of West Pharmaceutical Services, Inc. (WST) worth $172.94 M, representing 0.29% of the portfolio. First purchased in 2019-Q2, this long-term strategic position has been held for 26 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in WST, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 319,300 shares. Largest reduction occurred in Q1 2020, reducing 97,212 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's West Pharmaceutical Services (WST) Holding Value Over Time
Track share changes against reported price movement
Quarterly West Pharmaceutical Services (WST) Trades by Steven Cohen
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2019 | +1,200 | New Buy | 1,200 | $125.00 |
| Q3 2019 | +35,798 | Add 2983.17% | 36,998 | $141.82 |
| Q4 2019 | +90,195 | Add 243.78% | 127,193 | $150.33 |
| Q1 2020 | -97,212 | Reduce 76.43% | 29,981 | $152.26 |
| Q2 2020 | +41,316 | Add 137.81% | 71,297 | $227.18 |
| Q3 2020 | -9,588 | Reduce 13.45% | 61,709 | $274.90 |
| Q4 2020 | -23,591 | Reduce 38.23% | 38,118 | $283.30 |
| Q1 2021 | +8,739 | Add 22.93% | 46,857 | $281.77 |
| Q2 2021 | -16,729 | Reduce 35.70% | 30,128 | $359.10 |
| Q3 2021 | -5,400 | Reduce 17.92% | 24,728 | $424.54 |
| Q4 2021 | -24,728 | Sold Out | 24,728 | $0.00 |
| Q4 2022 | +534 | New Buy | 534 | $235.35 |
| Q1 2023 | +174,065 | Add 32596.44% | 174,599 | $346.47 |
| Q2 2023 | -174,599 | Sold Out | 174,599 | $0.00 |
| Q3 2023 | +183,591 | New Buy | 183,591 | $375.21 |
| Q4 2023 | -76,000 | Reduce 41.40% | 107,591 | $352.12 |
| Q1 2024 | +4,516 | Add 4.20% | 112,107 | $395.71 |
| Q2 2024 | -112,107 | Sold Out | 112,107 | $0.00 |
| Q4 2024 | +202,472 | New Buy | 202,472 | $327.56 |
| Q1 2025 | -74,185 | Reduce 36.64% | 128,287 | $223.88 |
| Q2 2025 | +211,666 | Add 164.99% | 339,953 | $218.80 |
| Q3 2025 | +319,300 | Add 93.92% | 659,253 | $262.33 |
Steven Cohen's West Pharmaceutical Services Investment FAQs
Steven Cohen first purchased West Pharmaceutical Services, Inc. (WST) in Q2 2019, acquiring 1,200 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held West Pharmaceutical Services, Inc. (WST) for 26 quarters since Q2 2019. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen's largest addition to West Pharmaceutical Services, Inc. (WST) was in Q3 2025, adding 659,253 shares worth $172.94 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 659,253 shares of West Pharmaceutical Services, Inc. (WST), valued at approximately $172.94 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, West Pharmaceutical Services, Inc. (WST) represents approximately 0.29% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen's peak holding in West Pharmaceutical Services, Inc. (WST) was 659,253 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.